TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Telix Pharmaceuticals Ltd. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights – TLX

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Levi & Korsinsky, Llp
Telix Pharmaceuticals Ltd. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights – TLX

Levi & Korsinsky, LLP has filed a class action securities lawsuit against Telix Pharmaceuticals Ltd. for alleged securities fraud between February 21, 2025 and August 28, 2025. The complaint alleges that defendants made false statements about prostate cancer therapeutic progress, overstated supply chain quality, and made materially misleading statements about business operations. Investors have until January 9, 2026 to request lead plaintiff status.

Insights
MRNA   neutral

Mentioned as a strategic collaboration partner with no specific details provided


TLX   negative

The company is the subject of a securities fraud class action lawsuit alleging material misstatements about therapeutic progress, supply chain quality, and business operations. This represents significant legal and reputational risk to investors.